ESRRA and triple-negative breast carcinoma: Interestingly, miR-497 has been also reported to target estrogen-related receptor alpha (ERRα), a nuclear receptor overexpressed in ERα negative breast cancer; downregulation of miR-497 is then responsible for ERRα induction and increased proliferation of triple-negative breast cancer cells (Han et al., 2016).